Page last updated: 2024-08-26

norcantharidin and Thrombosis

norcantharidin has been researched along with Thrombosis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chang, NC; Chou, DS; Geraldine, P; Hsia, CH; Jayakuma, T; Lin, KH; Lu, WJ; Sheu, JR	1

Other Studies

1 other study(ies) available for norcantharidin and Thrombosis

Article	Year
Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin α Journal of cellular and molecular medicine, 2018, Volume: 22, Issue:4 Topics: Adenosine Triphosphate; Adult; Antineoplastic Agents; Blood Coagulation; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Cell Adhesion; Enzyme Activation; Fibrinogen; Focal Adhesion Protein-Tyrosine Kinases; Humans; L-Lactate Dehydrogenase; P-Selectin; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protective Agents; Protein Binding; Signal Transduction; Thrombosis	2018

Article

Year

Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin α

Journal of cellular and molecular medicine, 2018, Volume: 22, Issue:4

Topics: Adenosine Triphosphate; Adult; Antineoplastic Agents; Blood Coagulation; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Cell Adhesion; Enzyme Activation; Fibrinogen; Focal Adhesion Protein-Tyrosine Kinases; Humans; L-Lactate Dehydrogenase; P-Selectin; Platelet Adhesiveness; Platelet Aggregation; Platelet Glycoprotein GPIIb-IIIa Complex; Protective Agents; Protein Binding; Signal Transduction; Thrombosis

2018